Panagiotis Vlachostergios

Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, United States

  • Orcid: 0000-0002-1704-1517
  • Publications: 102
  • Citations: 3533
  • Keywords: prostate cancer, urothelial carcinoma, kidney cancer, testicular cancer, cancer genetics, cancer genomics, immunooncology, precision oncology, cancer biomarkers, PSMA theranostics
Short Bio
  • Dr. Panagiotis J. Vlachostergios MD PhD is an Assistant Professor in the Department of Medicine, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York, NY, USA. Dr. Vlachostergios received his Ph.D. in Cancer Biology in 2013. He completed his Internal Medicine Residency at New York University School of Medicine, Langone Hospital and his Hematology and Medical Oncology Clinical Fellowship at Weill Cornell Medical College, New York Presbyterian Hospital. He has further completed post-doctoral training in Genomic Cancer Risk Assessment (City of Hope Comprehensive Cancer Center); Genetics and Genomics (Stanford University); Genetics, Cancer Genomics and Precision Oncology (Harvard Medical School); Immunology and Immuno-Oncology (Harvard Medical School); and Clinical Research (Weill Cornell Clinical and Translational Science Center). Dr. Vlachostergios has published more than 100 international peer-reviewed articles, and authored several book chapters and abstracts. His research has been highly cited and he is a recipient of prestigious awards from the American Society of Clinical Oncology, European Society of Medical Oncology, Society for Translational Oncology, American Federation for Medical Research, Bladder Cancer Advocacy Network, and others. His research interests include genitourinary oncology, prostate cancer, urothelial carcinoma, kidney cancer and testicular germ cell tumors.